Weighing costs, benefits of HIV treatments

Prevention versus treatment? Cost versus efficacy? So go two of the dilemmas looming over Dartmouth's Paul E. Palumbo and his fellow researchers in the race to fight HIV and other infectious diseases in the developing world - especially among women and their young children...

Read the whole article on

More from